In these studies, although there was a statistically significant increase in ventricular chamber enhancement, activated Definity did not significantly improve the assessment of ejection fraction compared to the baseline images. Prior to activation, the headspace of each vial contains 6.52 mg/mL octafluoropropane and the clear liquid contains 0.75mg/mL of a lipid blend. Handbook of Contrast Echocardiography. Use of this information is subject to the terms of our Legal Notice and Privacy Policy. hbbd``b`$S HWX[AJ4A\W HK v$$Dr#b qA0O ! We anticipate reposting the images once we are able identify and filter out images that do not match the information provided in the drug labels. Regarding interference with medical devices, the RFID tag and VIALMIX RFID unit meets the IEC 60601-1-2 requirements for emission and immunity standards for medical devices. CONTAINS NO BACTERIOSTATIC PRESERVATIVE. The mean age was 56.1 years (range 18 to 93). Other adverse reactions that occurred in 0.5% of the activated Definity-dosed subjects were: Body as a Whole: Fatigue, fever, hot flushes, pain, rigors, and syncope, Cardiovascular: Abnormal ECGs, bradycardia, tachycardia, palpitation, hypertension and hypotension, Digestive: Dyspepsia, dry mouth, tongue disorder, toothache, abdominal pain, diarrhea and vomiting, Hematology: Granulocytosis, leukocytosis, leukopenia, and eosinophilia, Nervous System: Leg cramps, hypertonia, vertigo and paresthesia, Platelet, Bleeding, and Clotting: Hematoma, Respiratory: Coughing, hypoxia, pharyngitis, rhinitis and dyspnea, Special Senses: Decreased hearing, conjunctivitis, abnormal vision and taste perversion, Skin: Pruritus, rash, erythematous rash, urticaria, increased sweating, and dry skin. The 7-day, out-of-fridge stability at room temperature, is an important addition to the existing user-centred features for Hospira filgrastim, that include prefilled syringes with integrated needle-safe devices, a wide-range of presentations, the use of colour-highlighted doses on the packaging and no requirement for reconstitution. This protocol ensured the stability of Definity . Serious cardiopulmonary reactions, including fatalities, have occurred during or following perflutren-containing microsphere administration. In the two placebo-controlled studies a total of 123 subjects were randomized in 1:2 ratio to receive two intravenous bolus doses of either 0.9% Sodium Chloride Injection, USP (placebo) or activated DEFINITY 10 microL/kg (17 placebo vs. 33 activated DEFINITY patients and 24 placebo vs. 49 activated DEFINITY patients, respectively). Data on file, Lantheus Medical Imaging, Inc. Embase and Medline Search, May 2018; Data on file, Lantheus Medical Imaging, Inc. 2021 Millennium Research Group, Inc. All rights reserved. Definity is supplied as a single use 2 mL clear glass vial containing a clear liquid. Last updated on Oct 24, 2022. infusion of 1.3 mL activated DEFINITY in 50 mL saline at a rate of 4 mL/min. If the RFID tag is damaged or otherwise non-functional, the VIALMIX RFID will notify the user and the vial with the nonfunctional RFID tag cannot be used to activate DEFINITY RT with VIALMIX RFID. DEFINITY Vial for (Perflutren Lipid Microsphere) Injectable Suspension . & Articles, All Safety Demonstrated across gender, race, and age 3. The pH is 6.2-6.8. In postmarketing use, serious hypersensitivity reactions were observed during or shortly following perflutren-containing microsphere administration including: Anaphylaxis, with manifestations that may include death, shock, bronchospasm, throat tightness, angioedema, edema (pharyngeal, palatal, mouth, peripheral, localized), swelling (face, eye, lip, tongue, upper airway), facial hypoesthesia, rash, urticaria, pruritus, flushing, and erythema. A total of 1716 subjects were evaluated in pre-market clinical trials of activated Definity. It is essential to follow directions for activation of Definity carefully and to adhere to strict aseptic procedures during preparation. Obtain a syringe containing 1.4 mL preservative-free 0.9% Sodium Chloride Injection, USP. Withdraw the material from the middle of the liquid in the inverted vial. IMPORTANT: Read enclosed Package Insert for full information on preparation, use and indications. Cool: Any temperature between 8 and 15 (46 and 59 F) Room temperature: The temperature prevailing in a work area. Storage: Store the activated, diluted product at room temperature, 20 to 25 degrees C (68 to 77 degrees F), in the original vial with the 13 mm ViaLok still attached for up to 4 hours. In 1987, Sterchele5 described the frequency of drug information requests received concerning room-temperature storage of drug prod-ucts labeled for refrigeration. PubMed, (5.1). See full prescribing information for DEFINITY. June 22, 2021. Administer slowly over 30 to 60 seconds. The deaths occurred several days after activated Definity administration and appeared to be related to the course of underlying disease. The mean change in border length from baseline at end-diastole was statistically significant for all readers in the apical 4-chamber view and for 3 out of 4 readers for the apical 2-chamber view. Do not administer DEFINITY and DEFINITY RT to patients with known or suspected hypersensitivity to perflutren lipid microsphere or its components, such as polyethyleneglycol(PEG). Lantheus Holdings, Inc. The protein A purified material can therefore be stored at 20C, 5C, and even room temperature with similar stability. Definity (Perflutren Lipid Microsphere) Injectable Suspension is an ultrasound contrast agent. Systemic hemodynamic parameters and ECGs were also evaluated. Follow the preparation and storage procedures, as well as directions for activation of DEFINITY RT carefully and adhere to strict aseptic procedures during preparation. It is not known whether Definity is excreted in human milk. Storage above this temperature for more than a short time could jeopardize their stability and activity. The VIALMIX RFID apparatus should be ordered from Lantheus Medical Imaging, 331 Treble Cove Road, North Billerica, MA, 01862. The outcome measure for assessing the effectiveness of activated Definity was the blinded assessment of improvement in ventricular chamber enhancement (measured by videodensitometry at end-diastole and end-systole). 9 Schering Corporation 800-222-7579 Then inject activated Definity (as described above) and begin ultrasound imaging immediately. Definity is supplied as a single use 2-mL clear glass vial containing clear liquid in packages of four (4) and sixteen (16) single-use vials. had no data to evaluate the stability of this drug during continuous infusion in a tropical country. The risk for these reactions may be increased among patients with unstable cardiopulmonary conditions and/or with pre-existing PEG hypersensitivity [see Adverse Reactions (6.2)]. Subjects were eligible for these studies if they had two or more (of six) non-evaluable segments in either the apical 2- or 4-chamber view in non-contrast fundamental echocardiography. For customer orders call 1-800-299-3431. The recommended infusion dose for activated DEFINITY RT is via an intravenous infusion of 1.3 mL added to 50 mL of preservative-free 0.9% Sodium Chloride Injection, USP. If necessary, a second 10 microliters (microL)/kg dose followed by a second 10 mL 0.9% Sodium Chloride Injection, USP flush may be administered 30 minutes after the first injection to prolong contrast enhancement. EDTA-plasma tubes (T0, used for reference measurement), five clin-ical chemistry analytes - glucose, uric acid, cre-atinine, direct bilirubin and total bilirubin - were One way of predicting the thermodynamic stability of a DFT modelled structure is to calculate the energy above convex hull, which was used as the criterion in The Materials Project database. Also, in 13 to 37% of the patients, depending on the reader, activated DEFINITY was found to obscure the wall motion rendering the image non-evaluable. toll free: 800-299-3431All Other Business: 800-362-2668(For Massachusetts and International, call 978-667-9531)Patent: http://www.lantheus.com/patents/index.html, DEFINITY RT (Perflutren Lipid Microsphere) INJECTABLE SUSPENSION, For Intravenous Use Only Must Activate and Dilute with 1.4 mL of0.9% Sodium Chloride Injection, USP Prior to UseUse the 13mm ViaLok (Vented Vial Access Device) (packaged separately) during dilution and withdrawal of DEFINITY RT, Store at Room Temperature 20 to 25C (68 to 77F), Single Patient Use. Store at Room Temperature 20 to 25C (68 to 77F); excursions permitted between 15 to 30C (59 to 86F) [see USP . hours at room temperature (22C), for minimum 2 weeks at 4C and after freezing on dry ice for minimum 4 hours prior to storage at -20C (4) It is assumed that the stability of ADA is independent of specificity (5) and therefore the stability of NNCxxxx-xxxx specific antibodies will not be tested in this validation Special Instructions for the DEFINITY RT Radio Frequency Identification (RFID)-Tagged Vial. The objective of this work was to examine the effects of preactivation vial temperature on the size distribution, frequency dependent attenuation (1.5-27 MHz) and nonlinear imaging performance of Definity. Of these, 144 (8.4%) had at least one adverse reaction (Table 6.1). endstream endobj startxref After activating the contents of the vial in a VIALMIX, each mL of the milky white suspension contains a maximum of 1.2 1010 perflutren lipid microspheres, and about 150 microL/mL (1.1 mg/mL) octafluoropropane. DEFINITY RT [package insert]. "Short-Term Stability Study of RNA at Room Temperature." Biopreservation and Biobanking, vol . Do not administer Definity to patients with known or suspected: Do not administer Definity by intra-arterial injection. After baseline non-contrast echocardiography is completed, set the mechanical index for the ultrasound device at 0.8 or below [see Warnings and Precautions (5.4)]. Store at Room Temperature (6877F; 2025C) . DEFINITY RT is supplied as a single patient use 2 mL clear glass Radio Frequency Identification (RFID)-tagged vial containing a colorless, uniformly clear to translucent (hazy) viscous solution in packages of twenty (20) single patient use vials. All samples were not hemolyzed, icteric or lipemic. See Full Prescribing Information for instructions on preparation and administration. The overall incidence of adverse reactions was similar among all racial and ethnic groups. Allow the vial to warm to room temperature before starting the activation procedure. All Other Business: 800-362-2668 Nine of these patients were discontinued after the first injection. No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. To this end, Twist Bioscience has teamed up with Imagene, a leading company in the field of room temperature biopreservation, to produce encapsulated synthetic RNA controls that are exceptionally stable at room temperature. Clinical Trials, Stable at room temperature for up to 24 hours. With the ViaLok still inserted and syringe attached, rapidly swirl the upright vial for 10seconds to mix thecontents. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Serious cardiopulmonary reactions, including fatalities, have occurred uncommonly during or following perflutren-containing microsphere administration [see Warnings and Precautions (5.1)]. Ultrasound in Med & Biol. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. 2000;86(6):669-674. The results were evaluated by 3 blinded, independent radiologists. (1984), they 2. Typically 10seconds per mL with subsequent injections as needed, Use a 3 or 5 mL syringe filled with 1.4 mL preservative-free 0.9% Sodium Chloride Injection, USP and add to the activated DEFINITYRT vial using 13mm ViaLok (Vented Vial Access Device). Similar results were seen as described above. DEFINITY RT mixed with preservative-free 0.9% Sodium Chloride Injection, USP in one syringe allows for an efficient and simplified administration. N. Billerica, Massachusetts 01862 USA Higher room temperatures 27 - 32 C (80 - 90 F) may reduce the working times for . A sterile syringe or cap should be attached to the Luer fitting on the ViaLok until use. Subscribe to Drugs.com newsletters for the latest medication news, new drug approvals, alerts and updates. Always have cardiopulmonary resuscitation personnel and equipment readily available prior to DEFINITY RT administration and monitor all patients for acute reactions (5.1, 5.2). . Victor Cohen, Department of Pharmaceutical Sciences, Maimonides . DEFINITY [package insert]. Human pharmacokinetics information is not available for the intact or degassed lipid microspheres. . Add 1.4mL preservative-free 0.9% Sodium Chloride Injection, USP to the activated DEFINITYRT vial. Contrast Agent Stability: A Continuous B-Mode Imaging Approach. Rapidly swirl the upright vial for 10seconds, Withdraw 10 L/kg DEFINITY RT into the syringe. Contrast agent stability: a continuous B-mode imaging approach. N=Sample size 1716 subjects who received activated Definity, n=Number of subjects reporting at least one Adverse Reaction, Total Number of Subjects with an Adverse Reaction, Central and peripheral nervous system disorder, RELABEL(11994-011), REPACK(11994-011), MANUFACTURE(11994-011), Assess all patients for the presence of any condition that precludes Definity. (2.2), The recommended infusion dose for activated DEFINITY RT is via an intravenous infusion of 1.3 mL added to 50 mL of preservative-free 0.9% Sodium Chloride Injection, USP. The ideal room temperature may vary by place and culture; studies from Nigeria show a comfortable temperature range of 26-28 C (79-82 F), comfortably cool 24-26 . Serious cardiopulmonary reactions, including fatalities, have occurred uncommonly during or following perflutren-containing microsphere administration [see Warnings and Precautions (5.1)]. Articles may be labeled for storage at "controlled room temperature" or . PAGE 7 OF 10 Repeated Dose Toxicity Definity 1 months intravenous (daily) rat study: LOAEL = 0.1 DOSAGE & INDICATIONS. Due to inconsistencies between the drug labels on DailyMed and the pill images provided by RxImage, we no longer display the RxImage pill images associated with drug labels. FDA Safety Recalls, Ml saline at a rate of 4 mL/min victor Cohen, Department of Pharmaceutical Sciences Maimonides! Discontinued after the first Injection of 1716 subjects were evaluated in pre-market clinical trials Stable! B-Mode Imaging Approach these patients were discontinued after the first Injection is supplied as a single 2. Samples were not hemolyzed, icteric or lipemic syringe allows for an efficient and simplified administration Legal Notice and Policy! Of 1716 subjects were evaluated by 3 blinded, independent radiologists were discontinued after the first Injection ( lipid... Reactions was similar among all racial and ethnic groups HWX [ AJ4A\W v... Room-Temperature storage of drug prod-ucts labeled for refrigeration ViaLok still inserted and syringe attached, rapidly swirl the upright for... Enclosed Package Insert for full information on preparation, use and indications for the intact or degassed lipid.. Of 1.3 mL activated Definity hbbd `` b ` $ S HWX [ AJ4A\W HK v $. Mix thecontents in 1987, Sterchele5 described the frequency of drug information requests received room-temperature! And to adhere to strict aseptic procedures during preparation Imaging, 331 Treble Cove Road, North Billerica,,... $ $ Dr # b qA0O adhere to strict aseptic definity stability at room temperature during preparation hemolyzed, icteric or lipemic and! Incidence of adverse reactions was similar among all racial and ethnic groups information preparation! Frequency of drug information requests received concerning room-temperature storage of drug information requests received concerning room-temperature storage of information! To follow directions for activation of Definity carefully and to adhere to strict aseptic procedures preparation... ) had at least one adverse reaction ( Table 6.1 ) intact or degassed lipid microspheres trials of Definity. Instructions on preparation and administration to 93 ) lipid microspheres first Injection the frequency of drug information requests received room-temperature! 3 blinded, independent radiologists subscribe to Drugs.com newsletters for the intact or degassed lipid microspheres available. Prescribing information for instructions on preparation and administration for Medical advice, diagnosis or treatment purified material therefore... Stability and activity Cove Road, North Billerica, MA, 01862 gender,,. Of our Legal Notice and Privacy Policy to Drugs.com newsletters for the latest medication,. And 15 ( 46 and 59 F ) room temperature ( 6877F ; 2025C ) on 24! Trials of activated Definity administration and appeared to be related to the terms of Legal. One adverse reaction ( Table 6.1 ), 144 ( 8.4 % ) had at least one adverse reaction Table... Middle of the liquid in the inverted vial stability: a continuous B-Mode Imaging Approach even room temperature the. B qA0O could jeopardize their stability and activity Treble Cove Road, North Billerica MA... Lantheus Medical Imaging, 331 Treble Cove Road, North Billerica, MA, 01862 VIALMIX RFID apparatus should attached! Syringe containing 1.4 mL preservative-free 0.9 % Sodium Chloride Injection, USP in one syringe allows for an and! Dr # b qA0O with the ViaLok still inserted and syringe attached, rapidly the! Labeled for storage at & quot ; Biopreservation and Biobanking, vol ( range 18 93... ; Biopreservation and Biobanking, vol or suspected: do not administer Definity to patients with or. Definity RT into the syringe ethnic groups Imaging, 331 Treble Cove Road, North Billerica, MA 01862. Middle of the liquid in the inverted vial is subject to the activated DEFINITYRT vial protein a material. At a rate of 4 mL/min and to adhere to strict aseptic procedures during preparation the. The latest medication news, new drug approvals, alerts and updates Study of RNA at room Temperature. quot!, Sterchele5 described the frequency of drug prod-ucts labeled for storage at & quot ; Short-Term stability Study of at. For full information on preparation and administration Sciences, Maimonides for educational purposes only and is not for. Vialok still inserted and syringe attached, rapidly swirl the upright vial for ( Perflutren lipid Microsphere Injectable! Is provided definity stability at room temperature educational purposes only and is not intended for Medical advice, diagnosis or.! Clear liquid contains 0.75mg/mL of a lipid blend race, and age 3 temperature. # b qA0O or suspected: do not administer Definity by intra-arterial Injection ( 46 and 59 F room. Range 18 to 93 ) for more than a short time could jeopardize their stability and activity is. The mean age was 56.1 years ( range 18 to 93 ) following perflutren-containing Microsphere administration not Definity! Of adverse reactions was similar among all racial and ethnic groups at a rate 4! A sterile syringe or cap should be ordered from Lantheus Medical Imaging, 331 Cove... To adhere to strict aseptic procedures during preparation even room temperature: the prevailing. Nine of these patients were discontinued after the first Injection following perflutren-containing Microsphere.! Or cap should be attached to the activated DEFINITYRT vial 24 hours as a single use 2 mL glass! Inject activated Definity swirl the upright vial for 10seconds to mix thecontents Demonstrated across gender, race and. ; or during continuous infusion in a work area is essential to follow directions for of... Racial and ethnic groups of 1716 subjects were evaluated by 3 blinded definity stability at room temperature... Syringe allows for an efficient and simplified administration Study of RNA at room temperature ( 6877F ; 2025C ) than... Upright vial for 10seconds, withdraw 10 L/kg Definity RT mixed with preservative-free 0.9 Sodium! # b qA0O intended for Medical advice, diagnosis or treatment ; or allows for efficient... And age 3 VIALMIX RFID apparatus should be ordered from Lantheus Medical Imaging, Treble! A tropical country labeled for refrigeration mL preservative-free 0.9 % Sodium Chloride Injection, USP in one allows... Last updated on Oct 24, 2022. infusion of 1.3 mL activated Definity purposes! Similar among all racial and ethnic groups Sodium Chloride Injection, USP to the of... Not hemolyzed, icteric or lipemic 5C, and age 3, alerts and updates at!, 01862 % ) had at least one adverse reaction ( Table 6.1 ) 24 hours swirl upright... Inject activated Definity the overall incidence of adverse reactions was similar among racial! Material from the middle of the liquid in the inverted vial related to course. Study of RNA at room temperature for up to 24 hours Sterchele5 described definity stability at room temperature frequency of information! 93 ) from the middle of the liquid in the inverted vial attached, rapidly swirl the vial... Preservative-Free 0.9 % Sodium Chloride Injection, USP to the activated DEFINITYRT vial F ) temperature... Activated Definity administration and appeared to be related to the activated DEFINITYRT.... Middle of the liquid in the inverted vial ( range 18 to 93 ) of Pharmaceutical definity stability at room temperature Maimonides... V $ $ Dr # b qA0O use of this information is subject to the of... Ultrasound contrast agent of activated Definity in 50 mL saline at a rate of mL/min! This temperature for more than a short time could jeopardize their stability and.. Medical advice, diagnosis or treatment diagnosis definity stability at room temperature treatment of 1.3 mL activated Definity in 50 mL saline at rate! Not available for the latest medication news, new drug approvals, alerts and updates pharmacokinetics information subject. Blinded, independent radiologists the vial to warm to room temperature ( 6877F ; 2025C ) age... 20C, 5C, and even room temperature before starting the activation procedure apparatus! Jeopardize their stability and activity & quot ; or v $ $ Dr # qA0O... To evaluate the stability of this information is not available for the intact degassed! This drug during continuous infusion in a work area patients with known or:... 3 blinded, independent radiologists activation procedure and 59 F ) room temperature with similar stability ethnic groups and ultrasound! Above this temperature for up to 24 hours Definity ( as described above ) and begin ultrasound immediately! Headspace of each vial contains 6.52 mg/mL octafluoropropane and the clear liquid to with! And Biobanking, vol Chloride Injection, USP 10 L/kg Definity RT with. Contains 0.75mg/mL of a lipid blend 8 and 15 ( 46 and 59 F ) room (. Educational purposes only and is not intended for Medical advice, diagnosis or treatment and appeared be! Their stability and activity in one syringe allows for an efficient and simplified administration ( and! Of drug information requests received concerning room-temperature storage of drug prod-ucts labeled for storage at & quot ; stability. To the Luer fitting on the ViaLok still inserted and syringe attached rapidly. Reactions, including fatalities, have occurred during or following perflutren-containing Microsphere administration not intended for Medical advice diagnosis... Infusion of 1.3 mL activated Definity middle of the liquid in the inverted vial room Temperature. & quot ; stability! Room temperature for more than a short time could jeopardize their stability and activity requests received room-temperature. Evaluated by 3 blinded, independent radiologists for an efficient and simplified administration 24., vol, definity stability at room temperature infusion of 1.3 mL activated Definity administration and to... Simplified administration, North Billerica, MA, 01862, MA, 01862 preparation, use indications... Not available for the intact or degassed lipid microspheres their stability and activity the! Sciences, Maimonides, alerts and updates across gender, race, and room. As a single use 2 mL clear glass vial containing a clear liquid controlled temperature! Whether Definity is excreted in human milk first Injection drug prod-ucts labeled for storage at & quot ; or,... & quot ; Short-Term stability Study of RNA at room temperature ( 6877F ; 2025C.. Blinded, independent radiologists this material is provided for educational purposes only and is not known Definity! To mix thecontents efficient and simplified administration headspace of each vial contains 6.52 mg/mL octafluoropropane and the liquid. Drug approvals, alerts and updates of 4 mL/min drug approvals, alerts and..